# DiaMedica Therapeutics Inc.: Form 8-K, filed Sep 5, 2023

- Company: [DiaMedica Therapeutics Inc.](/companies/dmac.md) (CIK 1401040)
- Form: 8-K
- Filed: 2023-09-05
- Accepted by EDGAR: Sep 5, 2023, 16:15 ET
- Period: 2023-09-03
- Accession: 0001437749-23-025203
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1401040/000143774923025203/dmtp20230903_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1401040/000143774923025203/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1401040/000143774923025203/dmtp20230903_8k.htm

Filed Sep 5, 2023.
Source: SEC EDGAR, the filing index for accession 0001437749-23-025203. Last ingested by Listed: Oct 24, 2026, 15:09 ET. No prices; not investment advice.